Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease

Pharmacopsychiatria. 1983 Jul;16(4):107-10. doi: 10.1055/s-2007-1017459.


Hypersexuality induced by dopaminergic drug treatment in parkinsonian patients is a rarely reported side-effect. A case history is presented where it occurred together with hyperkinesias while the patient was treated with L-dopa and bromocriptine. An addictive misuse of these drugs complicate the guidance of this patient. Approximately three years after the beginning of hypersexuality he developed several paranoid-hallucinatory psychoses which subsided each time upon dose reduction.

Publication types

  • Case Reports

MeSH terms

  • Benserazide / adverse effects
  • Benserazide / therapeutic use
  • Bromocriptine / adverse effects*
  • Bromocriptine / therapeutic use
  • Dopamine / physiology*
  • Female
  • Humans
  • Levodopa / adverse effects*
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Sexual Dysfunction, Physiological / chemically induced*


  • Bromocriptine
  • Levodopa
  • Benserazide
  • Dopamine